| | | | | | The Economist this week | | | | | | Our coverage of the new coronavirus | | | | | | | | | |
| | | | | | | | | | Welcome to the newsletter highlighting The Economist’s best pandemic coverage. Our cover this week looks at what to expect from life after lockdowns. What we call the 90% economy will be missing large chunks of everyday life—at least until a vaccine or a treatment is found. People are weighed down by financial hardship and the fear of a second wave of covid-19. Businesses are short of money. The unemployed could face a lost decade.
Our coverage of the disease this week sleuths into the genetic origins of the virus. SARS-CoV-2 almost certainly travelled from a bat to a person via an animal in the wet market in Wuhan—but it could conceivably have escaped from one of the town’s biological laboratories. We estimate how many years victims lose to covid-19 and weigh up the costs and benefits of closing schools. We look at the immune system, China’s determination to stamp out the disease and how nicotine may affect the rate of infection by competing with the virus to bind with human cells.
We also have a mortality tracker, which uses the gap between the total number of people who died from any cause and the historical average for the time of year to estimate how many deaths from covid-19 the official statistics are failing to pick up.
We have been focusing on the pandemic in Economist radio and Economist films, too. In Babbage, our science podcast, Pascal Soriot, chief executive of the pharmaceutical giant AstraZeneca, talks about potential treatments. We ask whether people who have recovered from covid-19 can catch it a second time. And Sonja Lyubomirsky, of the University of California, Riverside, tells us how acts of kindness can boost the immune system.
For those of us chafing under lockdown, perhaps her words will offer some encouragement. | | | | | | Zanny Minton Beddoes, Editor-in-Chief | | | | | | | | |
| | This e-mail has been sent to: newsletter@gmail.com If you'd like to update your details please click here (you may need to log in). Replies to this e-mail will not reach us.
If you no longer wish to receive this newsletter, unsubscribe here.
| | | | | | |